Retail sale of pharmaceutical products
RMF INVEST AS
Revenue 2025
NOK 142,000
Operating profit
NOK 24,000
Equity
NOK 12.8m
Incorporated
2005
Share capital
NOK 255,000
Key figures · 2025
Current ratio
5.67
Equity ratio
82.4%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 16.6% | |
| Net margin (%%) | 12477.2% | |
| Return on assets (%%) | 0.2% | |
| Likviditet | ||
| Current ratio | 5.67 | |
| Working capital | 12.8m | |
| Soliditet | ||
| Equity ratio (%%) | 82.4% | |
| Debt-to-equity ratio | 0.21 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.